Showing results (141-150 of 2,109) with videos related to
Sort By:
Pageof 211
Clinical Nephrology|March 30, 2007
Darbepoetin alfa once every 2 weeks for treatment of anemia in dialysis patients: a combined analysis of eight multicenter trialsJ Mann, M Kessler, G Villa, et al.Scandinavian Journal of Clinical and Laboratory Investigation|October 31, 2008
Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetesM S Christiansen, K Iversen, C T Larsen, et al.Acta Endocrinologica|June 1, 1976
Secretin-induced insulin response. I. Cubital insulin concentration in normal, obese and pancreatectomized patients, including portal insulin concentration in normals after secretinB Enk, B Lund, A Schmidt, et al.Diabetologia|May 1, 1983
Pharmacokinetics of continuous subcutaneous insulin infusionT Lauritzen, S Pramming, T Deckert, et al.Diabetologia|August 1, 1985
The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitusK Borch-Johnsen, P K Andersen, T DeckertDiabetologia|August 22, 2000
Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in Type I diabetesP Ekbom, P Damm, K Nøgaard, et al.Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1992
Transcapillary filtration of plasma protein in long-term type 1 (insulin dependent) diabetic patientsA Kofoed-Enevoldsen, L Bent-Hansen, T DeckertDiabetologia|June 1, 1993
Glucosaminyl N-deacetylase in cultured fibroblasts; comparison of patients with and without diabetic nephropathy, and identification of a possible mechanism for diabetes-induced N-deacetylase inhibitionA Kofoed-Enevoldsen, J S Petersen, T DeckertEuropean Journal of Clinical Pharmacology|November 16, 1978
Absorption, effectiveness and side effects of highly purified porcine NPH-insulin preparations (Leo)K Kølendorf, P Aaby, S Westergaard, et al.Hormone and Metabolic Research. Supplement Series|January 1, 1979
Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator)J S Christiansen, P A Svendsen, T DeckertPageof 211